Cas no 52227-33-5 (1-(azepan-1-yl)-2-chloroethan-1-one)
1-(azepan-1-yl)-2-chloroethan-1-one Chemical and Physical Properties
Names and Identifiers
-
- 1-(Chloroacetyl)azepane
- 1-(chloroacetyl)azepane(SALTDATA: FREE)
- 1-azaperhydroepinyl-2-chloroethan-1-one
- 1-Azepan-1-yl-2-chloro-ethanone
- AC1MJW9A
- CTK4J5629
- F9995-0397
- SureCN227972
- 1-(azepan-1-yl)-2-chloroethan-1-one
- STL371951
- EN300-01740
- Z56862394
- CS-0072018
- ALBB-011972
- G30682
- AKOS000267180
- 1-Azepan-1-yl-2-chloroethanone
- VS-09076
- 1-(azepan-1-yl)-2-chloroethanone
- DTXSID70389773
- BBL029014
- OUYNYRUBFQVLEE-UHFFFAOYSA-N
- AT-057/40257590
- SCHEMBL227972
- 1H-Azepine, 1-(chloroacetyl)hexahydro-
- 52227-33-5
- 1-(1-azepanyl)-2-chloro-1-ethanone
- MFCD00791327
- 1-(2-chloroacetyl)perhydroazepine
-
- MDL: MFCD00791327
- Inchi: 1S/C8H14ClNO/c9-7-8(11)10-5-3-1-2-4-6-10/h1-7H2
- InChI Key: OUYNYRUBFQVLEE-UHFFFAOYSA-N
- SMILES: ClCC(N1CCCCCC1)=O
Computed Properties
- Exact Mass: 175.07652
- Monoisotopic Mass: 175.076
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- Complexity: 130
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 20.3A^2
- XLogP3: 1.5
Experimental Properties
- Density: 1.112
- Boiling Point: 287.8°C at 760 mmHg
- Flash Point: 127.9°C
- Refractive Index: 1.485
- PSA: 20.31
1-(azepan-1-yl)-2-chloroethan-1-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 042002-1g |
1-(Chloroacetyl)azepane |
52227-33-5 | 95% | 1g |
£55.00 | 2022-03-01 | |
| Fluorochem | 042002-2.5g |
1-(Chloroacetyl)azepane |
52227-33-5 | 95% | 2.5g |
£109.00 | 2022-03-01 | |
| TRC | B418340-25mg |
1-(Chloroacetyl)azepane |
52227-33-5 | 25mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B418340-50mg |
1-(Chloroacetyl)azepane |
52227-33-5 | 50mg |
$ 104.00 | 2023-04-18 | ||
| TRC | B418340-250mg |
1-(Chloroacetyl)azepane |
52227-33-5 | 250mg |
$ 517.00 | 2023-04-18 | ||
| Chemenu | CM200448-5g |
1-(Chloroacetyl)azepane |
52227-33-5 | 97% | 5g |
$176 | 2024-07-15 | |
| Chemenu | CM200448-10g |
1-(Chloroacetyl)azepane |
52227-33-5 | 97% | 10g |
$309 | 2024-07-15 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTEN15405-1G |
1-(azepan-1-yl)-2-chloroethan-1-one |
52227-33-5 | 95% | 1g |
¥ 316.00 | 2023-04-13 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTEN15405-5G |
1-(azepan-1-yl)-2-chloroethan-1-one |
52227-33-5 | 95% | 5g |
¥ 1,181.00 | 2023-04-13 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTEN15405-10G |
1-(azepan-1-yl)-2-chloroethan-1-one |
52227-33-5 | 95% | 10g |
¥ 2,072.00 | 2023-04-13 |
1-(azepan-1-yl)-2-chloroethan-1-one Related Literature
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
Additional information on 1-(azepan-1-yl)-2-chloroethan-1-one
Recent Advances in the Study of 1-(Azepan-1-yl)-2-chloroethan-1-one (CAS: 52227-33-5)
1-(Azepan-1-yl)-2-chloroethan-1-one (CAS: 52227-33-5) is a chemical compound of significant interest in the field of medicinal chemistry and drug discovery. Recent studies have explored its potential as a versatile intermediate in the synthesis of pharmacologically active molecules. This research brief aims to summarize the latest findings regarding its synthesis, applications, and biological activities, providing valuable insights for researchers in the chemical and biomedical fields.
The compound has garnered attention due to its unique structural features, which make it a promising candidate for the development of novel therapeutic agents. Recent publications highlight its role in the synthesis of heterocyclic compounds, which are often key scaffolds in drug design. For instance, a 2023 study demonstrated its utility in the preparation of azepane-based inhibitors targeting specific enzymes involved in inflammatory pathways.
In terms of synthetic methodologies, advancements have been made in optimizing the yield and purity of 1-(azepan-1-yl)-2-chloroethan-1-one. A recent paper published in the Journal of Organic Chemistry detailed a novel green chemistry approach using microwave-assisted synthesis, which significantly reduced reaction times and improved environmental sustainability. This method aligns with the growing demand for eco-friendly processes in pharmaceutical manufacturing.
Biological evaluations of derivatives of 1-(azepan-1-yl)-2-chloroethan-1-one have revealed promising activities. For example, a 2024 study identified several analogs with potent antimicrobial properties against drug-resistant bacterial strains. These findings underscore the compound's potential as a lead structure for developing new antibiotics, addressing the urgent need for novel antimicrobial agents in the face of rising resistance.
Furthermore, computational studies have provided insights into the molecular interactions of 1-(azepan-1-yl)-2-chloroethan-1-one derivatives with biological targets. Molecular docking simulations and QSAR analyses have been employed to predict binding affinities and optimize structural modifications for enhanced efficacy. Such in silico approaches are increasingly valuable in accelerating drug discovery pipelines.
In conclusion, 1-(azepan-1-yl)-2-chloroethan-1-one (CAS: 52227-33-5) continues to be a compound of high relevance in chemical and biomedical research. Its applications span from synthetic chemistry to drug development, with recent studies highlighting its versatility and potential. Future research directions may focus on expanding its utility in targeted therapies and further optimizing synthetic protocols to meet industrial-scale demands.
52227-33-5 (1-(azepan-1-yl)-2-chloroethan-1-one) Related Products
- 2567-59-1(N,N-Dibutyl-2-chloroacetamide)
- 14368-26-4(1-(chloroacetyl)azocane)
- 158890-30-3(Ethanone,2-chloro-1-(4,4-dimethyl-1-piperidinyl)-)
- 2567-50-2(2-Chloro-N,N-Dicyclohexylacetamide)
- 2567-56-8(2-Chloro-N-cyclohexyl-N-methylacetamide)
- 33681-23-1(2-chloro-1-(2,6-dimethylpiperidin-1-yl)ethan-1-one)
- 2567-60-4(Acetamide,2-chloro-N,N-dipentyl-)
- 2567-61-5(2-chloro-N-cyclohexyl-N-ethylacetamide)
- 20266-00-6(2-chloro-1-(pyrrolidin-1-yl)ethan-1-one)
- 1440-60-4(2-chloro-1-(piperidin-1-yl)ethan-1-one)